Hospitalizations for pediatric catatonia in neurodivergent and neurotypical patients

James Luccarelli1, Jacqueline A Clauss1, Tasia York2

  • 1Harvard Medical School, Boston, MA, USA; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.

PubMed

Insights

Pediatric catatonia treatment shows high improvement rates, with benzodiazepines and ECT used similarly across neurodevelopmental disorder groups. However, neurotypical youth experienced longer hospital stays and better outcomes for non-medical diagnoses.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pediatric Medicine

Background:

  • Catatonia is a neuropsychiatric disorder in children, often co-occurring with neurodevelopmental disorders (NDDs).
  • Understanding hospital care patterns and treatment variations for pediatric catatonia is crucial.

Purpose of the Study:

  • To describe hospital care for pediatric catatonia.
  • To compare treatments and outcomes for neurotypical children versus those with NDDs.

Main Methods:

  • Retrospective cohort study (2018-2023) at two academic medical centers.
  • Inclusion of patients aged 18 and younger diagnosed with catatonia.
  • Assessment of treatment response using Clinical Global Impressions-Improvement (CGI-I) by independent reviewers.

Main Results:

  • Over 50% of 165 hospitalized pediatric catatonia patients had an NDD.
  • Benzodiazepine and electroconvulsive therapy (ECT) use were similar between groups.
  • Neurotypical patients had longer hospitalizations than those with NDDs.
  • An 88.3% probability of significant clinical improvement (CGI-I < 3) was observed.

Conclusions:

  • Pediatric catatonia shows a high likelihood of treatment response.
  • While treatments like benzodiazepines and ECT were administered similarly, neurotypical patients experienced longer hospitalizations.
  • Further research is needed for equitable and optimized catatonia treatment in youth.
Abstract